Biotech / Pharmaceutical
Functional insights for informed decision making
Over the last decade, the biopharmaceutical industry has seen a rapid increase in costs combined with a dramatic drop in returns on R&D investment. The cause of most program failures or delays is an incomplete understanding of the behavior and impact of drug candidates in vivo to inform decision making. As the complexity of drug development continues to increase, with increasing focus on more tailored treatments for unique patient phenotypes, the need for a tool to provide a broad and deep real-time view of biological pathways has never been greater.
Because metabolomics dynamically assesses a living system and links it to physiological changes induced by disease and drug response, as well as xenobiotic and microbiome influences, it provides researchers with comprehensive and readily interpretable biological insights that can be applied at every phase of the drug development process to keep your program tracked for success.
With our 20 years of metabolomics experience, we can help you design a study that tailored to your unique molecule and research needs to improve confidence, reduce risk of failure and make more informed decisions that save you time, money and re-work.